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Abstract
Recent data have indicated a relationship between placental oxygen and angiogenic protein levels in the first trimester of
normal pregnancies. Our objective was to investigate if maternal serum levels of angiogenic factors Soluble vascular
endothelial growth factor (VEGF) receptor 1 (sFlt-1), soluble Endoglin and placental growth factor (PlGF) are altered in
women with symptoms of threatened miscarriage (TM) and if they are predictive of a subsequent miscarriage. Blood
samples were collected at 6–10 weeks from women presenting with TM (n=40), from asymptomatic controls (n=32) and
from non- pregnant women in their luteal phase (n=14). All samples were assayed for serum level of sFLT-1, PlGF, sEndoglin
and HSP70 using commercial ELISAs. Samples were analysed retrospectively on the basis of pregnancy outcome. TM group
included 21 women with a normal pregnancy outcome and 19 with subsequent complete miscarriage. The latter subgroup
had significantly lower mean maternal serum (MS) sFlt-1 (83%, P,0.001) and PlGF (44%, P,0.001) compared to those with a
normal pregnancy outcome. Asymptomatic control pregnant women had similar MS levels of sFlt-1 and PlGF compared to
the TM patients with a normal outcome. The mean MS sFlt-1 (.10 fold) and MS PlGF (,2 fold) levels were significantly
(P,0.001) higher in control pregnant women compared to the non-pregnant group in the luteal phase of the menstrual
cycle. Soluble Endoglin was not altered in the normal pregnant women compared to non pregnant women, although lower
in the TM subgroup with a subsequent miscarriage (,25%, P,0.001) compared to TM with a live birth. There was no
significant difference in the mean MS HSP 70 levels between the different groups. This study shows that sFlt1 and PlGF MS
levels are increased by several folds in early pregnancy and that MS sFlt-1 and MS PlGF are markedly decreased in
threatened miscarriage patients who subsequently have a miscarriage suggesting these proteins are sensitive predictive
markers of subsequent pregnancy loss.
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Introduction
Placenta related disorders of pregnancy are the most common
complications of human pregnancies. Collectively, complete
miscarriages, missed miscarriages, recurrent miscarriages, threat-
ened miscarriages and placental insufficiency associated or not
with maternal hypertensive disorders affect more than 30% of
clinical pregnancies in humans. These placental disorders are
exceptional in other mammalian species [1,2].
Human placentation is characterized by the highly invasive
nature of the conceptus which embeds itself completely within the
maternal uterine endometrium and superficial myometrium and
by a remodelling of the tip of the maternal spiral arteries [1]. In
normal pregnancies, the earliest stages of development takes place
in a low oxygen (O2) environment [3,4]. This physiological
hypoxia of the early gestational sac protects the developing fetus
against the deleterious and teratogenic effects of O2 free radicals.
A stable O2 gradient between the maternal uterine decidua and
the feto-placental tissue is also an important factor in trophoblast
differentiation and migration, normal villous development and
angiogenesis [5,6].
Previous studies have shown that in normal pregnancies there is
a physiological oxidative stress in the placental tissue at around 9–
10 weeks which is evidenced by an increase in HSP70 activity
mainly in the periphery of the primitive placenta [7–9]. The
villous changes observed in the periphery of the placenta during
the formation of the fetal membranes are identical to those found
in the missed-miscarriage indicating a common mechanism
mediated by oxidative stress [8–10]. A missed miscarriage is
identified before the expulsion of the fetus or placental tissue. It is
diagnosed by ultrasound on the basis of absent fetal heart activity
after 5 weeks of gestation or in the presence of an empty
gestational sac. Threatened miscarriage (TM) is diagnosed when
normally grown live fetus is found on ultrasound in the presence of
vaginal bleeding [11]. TM is associated with focal oxidative stress
in the definitive placenta and increases the possibility of adverse
pregnancy outcomes such as miscarriage, preterm delivery and
premature rupture of the membranes [11].
The oxidative stress and rise in oxygenation may alter the
synthesis of various placental proteins. Maternal serum concen-
trations of hCG peak towards the end of the first trimester and
oxidising conditions promote assembly of the sub-units in vitro
PLoS ONE | www.plosone.org 1 March 2011 | Volume 6 | Issue 3 | e18041[12]. Our recent data showing an association between intrauterine
O2 concentration in vivo and inhibin A and sFlt-1 concentrations
in early pregnancy suggest that specific placental proteins may be
regulated by intrauterine O2 concentration [13].
In early pregnancy failure, the development of the placento-
decidual interface is severely impaired leading to early and
widespread onset of maternal blood flowing continuously inside the
placenta, together with major oxidative stress induced tissue
degeneration [8,9,13]. The excessive entry of maternal blood inside
the placenta in the early stage of most miscarriages is unrelated to
conceptus karyotype
10. In more than two-thirds of the cases of missed
miscarriage, there is anatomical evidence of defective placentation
with reduced cytotrophoblast invasion of the endometrium, reduced
transformation and incomplete plugging of the spiral arteries [14–17].
Angiogenesis is characterised by increased vascular permeabil-
ity, endothelial cell proliferation and migration. It is regulated by
various pro- and anti-angiogenic factors, angiopoietins and matrix
metalloproteinases. Anti-angiogenic and pro-angiogenic factors
are reported to play an important role in the pathophysiology of
pre-eclampsia (PE) [18]. Soluble Endoglin (sEndoglin) is a soluble
TGF-beta co-receptor. sEndoglin inhibits the formation of blood
vessels and induces vascular permeability and hypertension [19].
sFlt-1 is soluble vascular endothelial growth factor (VEGF)
receptor 1. sFlt-1 binds to the proangiogenic growth factors
VEGF and placental growth factor (PlGF), thereby neutralizing
their functions. Angiogenic growth factors VEGF-A and (PlGF)
have been investigated extensively in normal and abnormal
placental vascular development [20–22]. Recent studies suggest
that pre-eclampsia, hypertension and proteinuria may be due to
an excess of circulating anti-angiogenic growth factors, most
notably sFlt1 and sEndoglin [19–21].
Angiogenic factors have not been previously evaluated in early
pregnancy complications. Abnormal vascularisation of the pla-
centa with increased oxidative damage is a common aetiology of
pre-eclampsia, fetal growth restriction due to placental insuffi-
ciency and early pregnancy failure [1,2]. The aims of this study
were to determine whether TM which is associated with a focal
oxidative stress in the definitive placenta is also associated with
changes in angiogenic factors and to investigate if maternal serum
levels of sFlt-1, PlGF and sEndoglin can be potential sensitive
markers of a subsequent complete miscarriage in women
presenting with a TM in the first trimester of pregnancy.
Methods
All pregnant women were recruited from the University College
London Hospital (UCLH) and the non-pregnant control samples
were obtained from UCL staff and students. This study was
approved by the University College London Hospitals Committee
on the Ethics of Human research. All women gave informed
written consent to participate in the study.
TM was defined as vaginal bleeding with or without abdominal
pain during the first trimester of pregnancy and an ultrasound
examination showing an intrauterine gestational sac with a
normally grown live fetus with regular fetal heart beat within
normal ranges and with or without a subchorionic hematoma. The
blood sample was obtained from patients who attended the early
pregnancy unit with symptoms of TM. A viable pregnancy was
confirmed by scan on the day of blood collection. The outcome of
pregnancy was monitored until term.
Study groups
Bloodsampleswerecollectedaspart ofaprospectivecohortstudy
of women attending the early pregnancy clinic during the first
trimester of pregnancy. The outcomes of these patients were
followed as part of the prospective cohort study. TM with a
subsequent miscarriage outcome (n=19) and TM with a subse-
quent term live birth outcome (n=21) were selected retrospectively
from singleton spontaneousconceptionsmatched forgestational age
(65 days) at sampling, maternal age (65 years), BMI and smoking
status, for analysis. For comparison, blood samples collected from
asymptomaticpregnant women(n=32)matched for gestational age
(65 days) at sampling, maternal age (65 years), BMI and smoking
status in the first trimester and non-pregnant women in the luteal
phase (not on any medication) were analysed (20–35 years, n=14).
Demographic data of the different groups are summarized in
Table 1. Asymptomatic antenatal controls and TM live births had
normal pregnancy outcome at term.
All blood samples were taken in the first trimester between 6–10
weeks in gestation from Jan 2008-April 2010. Serum was
separated and frozen at 280uC until analysis.
Immunoassays
All samples were assayed for Soluble Flt-1, PlGF, sEndoglin and
heat shock protein 70 (HSP70) using commercial ELISAs.
Quantakine ELISA kits for PlGF and sFlt-1 and reagents from a
duo-set for sEndoglin was used from R&D systems (UK) to
measure the respective proteins in serum samples according to the
manufacturer’s protocol at the Reproductive Sciences laboratory,
UCL and at Anu Research Centre, UCC.
The minimum detection limit for the respective assays was PlGF:
3.9 pg/ml, sEng: 62.5 pg/ml, sFlt-1 31.3 pg/ml. Heat shock protein
70 was measured in serum using a highly sensitive assay kit from
Assays Design (Cambridge Bioscience, UK). The detection limit of
HSP 70 was 0.2 ng/ml. All samples were assayed in duplicates and
the intra and inter assay variations were ,12% for all assays.
Statistical Analysis
We carried out non parametric general linear model analysis of
variance controlling for maternal age using Dunnett’s T3 posthoc tests
because data were not normally distributed. Gestation at sampling and
BMI were not significantly different among the groups. Correlation
Table 1. Demographic details of the participants in the study given as median and interquartile range (25
th,7 5
th percentiles).
Non pregnant (Median
(25
th &75
th percentiles) N=14 Control pregnant N=32 TM-Live birth N=21
TM-Miscarriage
N=19
Gestation (days) - 50.5 (46, 58.5) 50.5 (42, 60) 51 (47, 59)
Maternal Age (years) 26 (24.75, 32.25) 32 (28.75, 35) 31 (25.5, 35) 34 (32, 40)
BMI 22.5 (20.16, 24.5) 22.61 (21.75, 25.52) 23.5 (21, 28.75) 24.5 (21.25, 27)
Birth weight (grams) - 3621(3123, 4057) 3220 (2738, 3580)
doi:10.1371/journal.pone.0018041.t001
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parameters. Data was presented as scatter plot with median and
interquartile range and P values were considered significant at P,0.05.
Results
The mean MS sFlt-1 level was significantly (P,0.001) higher
(.10 fold increase) in normal pregnancy compared to the non-
pregnant group whereas mean MS sFlt-1 levels were significantly
(86% decrease, P,0.001) lower in the TM subgroup with a
subsequent miscarriage compared to asymptomatic controls. TM
subgroup with a subsequent miscarriage had significantly lower
levels of sFlt-1 (83% decrease, P,0.001) compared to TM
subgroup with a subsequent live birth (Figure 1).
The mean MS PlGF levels were higher in pregnancy than in
non-pregnant controls (,2 fold increase, P,0.001). PlGF levels
were lower in TM patients with a subsequent miscarriage (44%
decrease, P=0.001) compared to TM patients who subsequently
had a term live birth. TM patients with subsequent miscarriage
had lower levels of PlGF (42% decrease, P=0.002) compared to
asymptomatic pregnant women (Figure 2).
There was no significant difference in the mean sEndoglin levels
between the non-pregnant and control pregnant women. Howev-
er, sEndoglin levels were modestly lower (,25%, P,0.001) in the
TM women who had a miscarriage compared to TM women who
had a live birth (Figure 3). Mean MS HSP70 levels were not
significantly different between all groups of pregnant women and
non-pregnant controls (Figure 4).
Bivariate correlation analysis showed a positive correlation
between gestational age and MS sFlt-1 (r=0.5, P,0.001) and
PlGF (r=0.42, P,0.001). Serum levels of sFlt-1 and PlGF
(r=0.57, P,0.001) were significantly associated. Endoglin was
positively correlated with gestational age (r=0.284, P=0.012).
Discussion
This study shows that maternal levels of sFlt-1 (83%) and PlGF
(44%) are distinctly lower in TM complicated by subsequent
miscarriage compared to normal pregnant controls and TM with
subsequent live birth. Our findings suggest that these molecules
could be used as potential predictive markers of miscarriage in
these women presenting with TM during the first trimester of
pregnancy at 6–10 weeks gestation. The development of
algorithms to predict miscarriage could help triaging for high-
risk couples with a history of recurrent miscarriages and for
women presenting with bleeding in early pregnancy. MS PlGF
and MS sFlt-1 levels were similar in TM with a normal obstetric
outcome and asymptomatic controls suggesting that the patho-
physiology of TM i.e. development of a subchorionic bleed does
not alter the production of the proteins by the placenta in early
pregnancy.
Previous studies have shown that endocrinological parameters
such as hCG, progesterone [23,24], PAPP- A and inhibin A [11]
levels are decreased in the first trimester in patients with symptoms
of TM who subsequently have a complete miscarriage compared
to those with a normal obstetric outcome. A recent community
based cohort study has investigated the association of self reported
first trimester bleeding with a subsequent miscarriage [25]. The
authors concluded that patients with heavy bleeding and
associated pain in the first trimester have three times more risk
of a complete miscarriage compared to asymptomatic women.
In the recent years, pro- and anti-angiogenic proteins have been
reported to be useful biomarkers in predicting pregnancy
complications such as pre-eclampsia and fetal growth restriction
[19–21]. In this study, we found that the levels of sFlt-1 rose .10
fold in pregnancy at 6–10 weeks gestation compared to luteal
phase of the menstrual cycle confirming that the feto-placental
unit is a major source for this molecule in early pregnancy. P1GF
also increased by almost 2 fold in early pregnancy. By contrast, no
difference was found in the concentrations of sEndoglin between
samples from non-pregnant women and from early pregnancy
controls suggesting that there could be multiple sources of this
protein.
Independent of the cause of an early pregnancy failure, the
premature and excessive entry of maternal blood inside the
placenta has two effects on the villous tissue. First a direct
Figure 1. Scatter plot of circulating levels of serum soluble VEGF receptor 1 (sFLT-1) in the different groups of women with median
and interquartile range. Group 1 (non-pregnant women, n=14), group 2 (normal pregnant women, n=32), group 3 (threatened miscarriage
patients with a live birth outcome, n=21) and group 4 (threatened miscarriage patients with a subsequent miscarriage, n=19). General linear analysis
of variance was carried out to study the statistical significance between the groups with posthoc tests. P,0.001=***.
doi:10.1371/journal.pone.0018041.g001
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embedded inside large intervillous blood thrombi and secondly an
indirect widespread O2-mediated effect causing oxidative damage
leading to major apoptosis and necrosis of the villous trophoblast
[8,26]. Overall, the consequences are placental degeneration with
complete loss of syncytiotrophoblast function and detachment of
the placenta from the uterine wall. This mechanism is common to
all miscarriages irrespective of the time at which it occurs in the
first trimester depending on the aetiology [1]. Oxidative stress is
also involved in the development of other placental-related
disorders such as pre-eclampsia and premature rupture of the
placental membranes [8,9].
We have recently shown that O2 concentration in the placental
bed blood is inversely related to sFlt-1 in early pregnancy [13]. A
Figure 2. Scatter plot of circulating levels of serum placental growth factor (PlGF) in the different groups of women with median
and interquartile range. Group 1 (non-pregnant women, n=14), group 2 (normal pregnant women, n=32), group 3 (threatened miscarriage
patients with a live birth outcome, n=21) and group 4 (threatened miscarriage patients with a subsequent miscarriage, n=19). General linear analysis
of variance was carried out to study the statistical significance between the groups with posthoc tests. P,0.001=***, P,0.01=**.
doi:10.1371/journal.pone.0018041.g002
Figure 3. Scatter plot of circulating levels of serum soluble Endoglin (sEndog) in the different groups of women with median and
interquartile range. Group 1 (non-pregnant women, n=14), group 2 (normal pregnant women, women, n=32), group 3 (threatened miscarriage
patients with a live birth outcome, n=21) and group 4 (threatened miscarriage patients with a subsequent miscarriage, n=19). General linear analysis
of variance was carried out to study the statistical significance between the groups with posthoc tests. P,0.001=***.
doi:10.1371/journal.pone.0018041.g003
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suggests that impaired placentation may be associated with
placental metabolic changes before the appearance of clinical
symptoms of miscarriage and these changes are modulated by an
abnormal increase in O2 concentration inside the placenta after
implantation.
Overall women presenting with TM are also more likely to
deliver prematurely and/or present with preterm pre-labour
rupture of membranes [11]. The presence of a haematoma may
also be associated with a chronic inflammatory reaction in the
decidua. This results in persistent myometrial activity and
expulsion of the pregnancy or progressive cellular dysfunction
and/or damage to cellular layers of the membranes leading to
preterm rupture and delivery [33].
HSP70 is a sensitive marker of oxidative stress in tissues. It is
reported to have a peak in the expression of HSP70 in the
placental tissue from normal pregnancies at 8–10 weeks when the
fetal membranes start to form [3]. We also found that the
immunoreactivity for HSP70 is greater in samples from peripheral
than from central regions of normal placentas and in the whole
placental tissue in missed miscarriage [3]. Early blood flow is
restricted to the peripheral regions of most normal placentas
whereas in missed miscarriages it is most common in central
regions or throughout the placenta [3,10]. Circulating levels of
HSP 70 in pre eclampsia, HELLP syndrome and preterm delivery
are reported to be increased in MS compared to normal
pregnancy suggesting HSP70 may reflect inflammation and
oxidative stress [26]. In the present study, we found no difference
in the MS HSP70 among the subgroups suggesting that peripheral
circulating HSP70 may not reflect focal changes in intrauterine
tissues. HSP70 is therefore unlikely to be useful in the screening for
early pregnancy loss.
There is evidence that the circulating cytokine levels and the
cytokine profile in the decidua are different in women who
experience recurrent miscarriages [27–30] but the exact interac-
tion of each of these cytokines with the invading trophoblast is not
well defined. Decreased expression of angiogenic factor genes for
basic fibroblast growth factor (FGF), intergrin aV and vascular
endothelial growth factor (VEGF) has also been observed in
placental samples from recurrent miscarriage patients [31]. There
are no reliable assays available to measure ‘total’ VEGF in
circulation and circulating levels of VEGF are almost below
detection in early pregnancy [13]. In the present study, we found
significantly (P,0.001) lower levels of sFlt-1 and P1GF in TM
patients with a subsequent miscarriage than in TM patients with a
subsequent live birth. Whereas the lowering of P1GF can be
related to a decreased syncytiotrophoblast synthesis, lower levels of
sFlt-1 may be compensatory as the placenta may be producing
more VEGF and less sFlt-1 that is bound to VEGF. On the other
hand, both VEGF and the receptor production may be lower in
patients who subsequently have a miscarriage thus reflecting lower
levels of sFlt-1 in maternal circulation in these cases. Although
lower PlGF is associated with pre-eclampsia and miscarriage,
levels of sFlt-1 and sEndoglin are raised in pre-eclampsia and
decreased in miscarriages suggesting a different mechanism in
miscarriage.
At present, there is no reliable marker to predict the clinical
outcome of women presenting with TM in the first trimester of
pregnancy although several potential markers have been studied
[23,24]. We have shown previously that at term, sFlt-1 rapidly
declines after the removal of the placenta with a ,50% decline
observed within 1 hr of delivery [32]. This suggests that, with its
short half-life in the maternal circulation, sFlt-1 could be a more
sensitive marker than molecules such as hCG which have a longer
half-life.
In this study, we have demonstrated that sFlt-1 and PlGF could
be new sensitive predictors of a subsequent miscarriage in TM
patients in the first trimester. Further larger studies are required to
investigate the predictive efficiency of these markers.
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Figure 4. Scatter plot of circulating levels of serum heat shock protein 70 (Hsp 70) in the different groups of women with median
and interquartile range. Group 1 (non-pregnant women, n=14), group 2 (normal pregnant women, n=32), group 3 (threatened miscarriage
patients with a live birth outcome, n=21) and group 4 (threatened miscarriage patients with a subsequent miscarriage, n=19). General linear analysis
of variance was carried out to study the statistical significance between the groups with posthoc tests. NS=not significant.
doi:10.1371/journal.pone.0018041.g004
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